Cancer Research at Saint John’s Cancer Institute Continues to Advance Scientific Understanding Across Oncology
Through laboratory discovery, clinical investigation, and multidisciplinary collaboration, researchers at Saint John’s Cancer Institute investigate new approaches to cancer prevention, diagnosis, treatment, and patient care. Their work contributes scientific evidence that may inform future clinical practices, help identify potential therapeutic targets, and support more personalized approaches to cancer treatment.
In 2025, Saint John’s Cancer Institute researchers contributed to 74 peer-reviewed scientific publications spanning more than a dozen medical specialties and subspecialties. These publications involved 34 scientists and clinicians working with research teams and collaborating investigators at institutions across the United States and internationally.
The studies address questions involving cancer biology, molecular diagnostics, immunotherapy, surgical oncology, translational medicine, neurologic care, and clinical outcomes.
Published in March 2026, the 2025 Saint John’s Cancer Institute Research Report documents these contributions and introduces an Executive Summary highlighting eight selected publications.
2025 Research Highlights and Scientific Collaboration
The Institute’s annual Research Report provides a record of scientific activity across laboratory and clinical disciplines. The 2025 edition introduces a more detailed Executive Summary to help readers understand the significance of selected research projects and their relevance to ongoing scientific investigation.
Eight Significant Publications Summarized
The Executive Summary highlights eight publications representing three principal areas of scientific investigation: Clinical Trials, Translational Research, and Clinical Research.
These selected studies address topics involving molecular biology, precision diagnostics, immunotherapy, surgery, and acute neurologic care.
Each research category contributes to a different stage of scientific development:
- Clinical Trials: Studies that evaluate medical interventions, treatment approaches, and their effects on participating patients under established research protocols.
- Translational Research: Investigations that connect molecular and laboratory discoveries with clinical questions, including the identification and validation of potential biomarkers and therapeutic targets.
- Clinical Research: Studies involving patient outcomes, diagnostic methods, treatment patterns, surgical techniques, and other questions relevant to medical practice.
The Executive Summary provides a closer look at how these investigations contribute to scientific knowledge and may inform future diagnostic or treatment strategies.
Some projects examine established therapies or clinical practices, while others investigate approaches that remain experimental. Research findings require appropriate validation before they can be considered established standards of care.
Read the 2025 Research Report and Executive Summary (PDF).
New Translational and Precision Medicine Laboratory
An important research development in 2025 was the establishment of the Translational and Precision Medicine (TPM) Laboratory, founded in October 2025 and led by Matias Bustos, PhD.
The TPM Laboratory supports cancer research involving molecular profiling, biomarker discovery, computational analysis, and digital pathology.
Its work integrates biological specimens, advanced sequencing technologies, and analytical methods to investigate molecular characteristics associated with cancer development, progression, and treatment response.
Research areas include circulating biomarkers, tumor molecular signatures, and methods for integrating laboratory findings with clinical data.
These investigations may help researchers develop and validate future approaches to cancer risk assessment, diagnosis, and treatment selection. Not all experimental biomarkers or methods are currently approved or established for routine clinical use.
The new laboratory complements the Institute’s longstanding molecular research activities, including work associated with Dave S. B. Hoon, PhD, whose research has contributed to understanding tumor biology, metastasis, and molecular mechanisms involved in cancer.
Research involving melanoma, microRNA, mRNA, and other molecular pathways continues to contribute to the Institute’s translational science programs.
Learn more about the Translational and Precision Medicine Laboratory and its research projects.
Fellowship-Driven Scientific Research
Scientific collaboration at Saint John’s Cancer Institute also includes surgical oncology fellows, research fellows, and other physicians in advanced specialty training.
Through faculty-fellow mentoring programs, trainees may participate in laboratory studies, clinical research, retrospective analyses, research conferences, and the preparation of scientific publications.
Projects span several areas, including translational molecular medicine, urologic oncology, breast cancer, neuroscience, endocrine disorders, complex general surgical oncology, and melanoma.
Faculty mentors help fellows develop research questions, evaluate published evidence, interpret study findings, and communicate results through presentations and manuscripts.
Fellow participation also supports research collaborations involving investigators at other institutions.
These experiences contribute to the development of physicians who can evaluate emerging scientific evidence and apply research principles in clinical practice.
Research Across Multiple Cancer Specialties
The 2025 publications demonstrate the breadth of the Institute’s scientific activities, extending across multiple cancer types and related medical disciplines.
Researchers investigated questions involving tumor biology, molecular pathways, surgical management, clinical outcomes, immunotherapy, precision diagnostics, and other aspects of cancer medicine.
Such work frequently requires collaboration among scientists, surgeons, medical oncologists, pathologists, geneticists, biostatisticians, and other specialists.
Research partnerships can provide access to additional expertise, datasets, technologies, and patient populations needed to investigate complex scientific questions.
These collaborations help strengthen the evidence base for future research and clinical decision-making, while the eventual effect on patient outcomes must be demonstrated through appropriate studies.
Recognizing the Researchers Behind the 2025 Publications
The 2025 Research Report reflects the collective efforts of scientists, physicians, research fellows, laboratory professionals, clinical teams, and collaborators whose contributions made these studies possible.
The 74 peer-reviewed publications involved 34 scientists and clinicians identified in the annual report, alongside additional research personnel and collaborators who contributed to experimental design, data analysis, clinical investigations, and scientific publication.
Saint John’s Cancer Institute recognizes the dedication of its researchers, clinicians, fellows-in-training, research staff, and administrators who support this work.
We also acknowledge the institutional, philanthropic, and collaborative support that makes continued scientific investigation possible.
Saint John’s Cancer Institute Annual Research Reports
The Institute publishes annual reports documenting peer-reviewed publications, scientific accomplishments, and research collaborations across its clinical and laboratory programs.
The 2025 edition continues the annual series established in 2022 and adds an Executive Summary highlighting eight selected studies.
Explore the current and previous reports below, or visit the Annual Research Reports archive.
SJCI Research Reports
- 2025 Research Report (PDF)
- 2024 Research Report (PDF)
- 2023 Research Report (PDF)
- 2022 Research Report (PDF)
Supporting Continued Cancer Research
The 2025 Research Report documents 74 peer-reviewed publications involving 34 scientists and clinicians at Saint John’s Cancer Institute. The year also marked the establishment of the Translational and Precision Medicine Laboratory, continued research collaboration across oncology specialties, and the contributions of fellows working alongside faculty investigators. Together, these achievements represent sustained scientific investigation aimed at advancing the understanding of cancer and evaluating new approaches to diagnosis, prevention, and treatment.
Explore the Annual Research Reports, learn more about Translational and Precision Medicine Research, and review the Institute’s Fellowship Programs. Scientific research is supported through institutional resources, research grants, partnerships, and philanthropic contributions. Those interested in supporting cancer research may visit Make a Donation.
Sources & Further Reading
- Saint John’s Cancer Institute — 2025 Research Report and Executive Summary (PDF)
- Saint John’s Cancer Institute — Annual Research Reports
- Saint John’s Cancer Institute — Translational and Precision Medicine Laboratory
- Saint John’s Cancer Institute — Matias Bustos, PhD
- Saint John’s Cancer Institute — Fellowship Programs




